Previous 10 | Next 10 |
2023-10-06 11:31:49 ET Shares of Accolade (NASDAQ: ACCD) were down more than 25% for the week as of 10 a.m. on Friday, according to data provided by S&P Global Market Intelligence . The healthcare benefits company's stock closed last week at $10.58 a share then fell to a...
2023-10-04 19:53:05 ET Accolade, Inc. (ACCD) Q2 2024 Earnings Conference Call October 4, 2023 4:30 PM ET Company Participants Todd Friedman - Senior Vice President, Investor Relations Rajeev Singh - Chief Executive Officer Steve Barnes - Chief Financial Officer ...
2023-10-04 16:07:54 ET More on Accolade Accolade: Consider Both Growth And Profitability Accolade: Leveraging Tech To Deliver Accessible Healthcare Accolade: Growth Reacceleration In FY25 Should Drive Valuation Upside Accolade FQ2 2024 Earnings Preview ...
SEATTLE, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal second quarter ended August 31, 2023. “We are halfway through the 2024 fiscal year and the demand environment for our solutions remains strong. Accolade continues...
Sumitomo Heavy Industries Ltd. ADR (SOHVY) is expected to report for Q1 2024 Art's-Way Manufacturing Co. Inc. (ARTW) is expected to report for Q2 2024 Resources Connection Inc. (RGP) is expected to report $0.12 for Q1 2024 Bullfrog AI Holdings Inc. (BFRG) is expected to report for Q1 ...
Accolade Inc. (ACCD) is expected to report $-0.56 for Q2 2024
2023-10-03 17:35:33 ET More on Accolade Accolade: Consider Both Growth And Profitability Accolade: Leveraging Tech To Deliver Accessible Healthcare Accolade: Growth Reacceleration In FY25 Should Drive Valuation Upside Seeking Alpha’s Quant Rating on Ac...
2023-10-03 17:35:26 ET ACCD For Seeking Alpha's full earnings season calendar, click here . For further details see: Notable earnings after Wednesday's close
2023-10-03 05:44:05 ET Summary Accolade is in a good position to meet its revenue growth guidance for both the current fiscal year and long term. There is a risk that ACCD's bottom line could fall short of expectations in subsequent quarters, and investors might be concerned about...
2023-09-29 15:00:29 ET More on the markets Historical Evidence Between Real Yields Suggests Further Slump For SPY Interest Rates Won't Be Higher For Longer: SPY Implications Rate environment today 'rhymes with 2008' - J.P. Morgan's Kolanovic Stocks in midst o...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
A look at the top 10 most actives in the United States Innovative Eyewear Inc. (LUCY) rose 50.0% to $0.495 on volume of 360,218,139 shares NVIDIA Corporation (NVDA) fell 0.4% to $123.54 on volume of 307,578,749 shares Ginkgo Bioworks Holdings Inc. Class A (DNA) rose 8.1% to $0.3343 on vol...